Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Mississippi for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Mississippi only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Mississippi (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Proteus Genomics, LLC (NPI 1558097592)

Key Findings

Field	Value
Entity Type	Organization
Organization	Proteus Genomics, LLC
Address	6766 U S Highway 98 Ste 1b
City	Hattiesburg
State	MS
ZIP	39402
Taxonomy	Clinical Medical Laboratory
NPI Enumerated	July 30, 2022

Payer Source	Total Paid
Medicare	$4.8M
Medicaid	$0

PROTEUS GENOMICS, LLC is a Clinical Medical Laboratory based in HATTIESBURG, MS with an NPI enumerated 2022-07-30 (~4 years ago). Its lifetime Medicare revenue is $4.8M and there is no Medicaid billing on file, making Medicare effectively the sole public payer in the available claims data for this entity.

Revenue is highly concentrated in a narrow set of molecular test codes: the precomputed top 3 Medicare codes account for 85.1% of the provider's Medicare revenue. In particular, 87798 ($2.8M, 58.8% of Medicare revenue) and 87481 ($1M, 21.8% of Medicare revenue) dominate the revenue mix, leaving the remainder of the portfolio contributing only a small share.

The code mix is heavily weighted to amplified nucleic acid probe techniques and related molecular infectious-disease testing (examples concentrated in 87798, 87481, 87640), indicating the operation functions primarily as a molecular diagnostics provider rather than a general clinical lab. High volumes in pathogen-specific nucleic acid tests (Candida, Staphylococcus aureus, other amplified-probe assays) suggest a service-line focused on infectious-agent detection and potentially centralized specimen processing.

Competitive standing on key Medicare tests is unusually strong: 87481 ranks #14 of 1117 providers nationally (99th percentile) and is labeled an "extreme outlier, far above typical national volume for this code." 87798 ranks #25 of 1319 providers (98th percentile) and is described as "notably above typical national volume for this code." These ranks indicate the provider is a major national contributor for several high-revenue molecular assays rather than a modest local participant.

Beyond the top two codes, several other amplified-probe assays also show above-typical national volume: 87640 ($214.1K, 4.5% of Medicare revenue) ranks #23 of 1017 (98th percentile), 87653 and 87500 each report $204.4K (4.3% each) and rank in the 98th percentile, and 87641 ($134.7K, 2.9%) ranks in the 96th percentile. This pattern—multiple different pathogen-specific molecular codes in the high percentiles—underscores a broad, high-volume molecular testing capability rather than dependence on a single niche assay.

Non-molecular or routine lab codes represent trivial revenue by comparison: for example, 81003 shows 1.2K claims for $2.4K revenue and ranks #482 of 51536 providers (99th percentile) but contributes only 0.1% of Medicare revenue. COVID-specific high-throughput codes are present but small in scale (U0003: 82 claims, $6.1K revenue, 49th percentile; U0005: 82 claims, $2.1K revenue, 47th percentile), indicating the practice's primary business is ongoing molecular infectious testing rather than episodic pandemic testing.

For payer and contracting strategy, the combination of a single-payer Medicare revenue base ($4.8M) and extreme concentration in a few amplified-probe codes (top 3 = 85.1% of Medicare revenue) signals concentrated reimbursement exposure: negotiations, audits, or price adjustments focused on those dominant codes would disproportionately affect overall revenue. The provider's rapid ascent to high national ranks for multiple pathogen-specific molecular tests within ~4 years of NPI enumeration suggests operational scale-up in targeted molecular assays that payers should monitor as part of network strategy and utilization management.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
87798	The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified…	81,350	$30	$2.8M
87481	The lab analyst performs a test for Candida species using amplified nucleic acid probe technique.	30,170	$30	$1M
87640	The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique.	6,300	$30	$214.1K
87653	The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,…	6,010	$30	$204.4K
87500	The lab analyst performs a test for vancomycin resistance in an infectious organism’s nucleic acid using amplified probe technique. VRE, vancomycin resistant enterococcus, is the most common organism…	6,010	$30	$204.4K
87641	The lab analyst performs a test for methicillin–resistant Staphylococcus aureus (MRSA) using an amplified nucleic acid probe technique.	3,960	$30	$134.7K
87651	The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat.	1,870	$30	$63.6K
87631	The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,…	180	$140	$24.8K
87502	The lab analyst performs a test to determine the presence of multiple types or subtypes of influenza virus through nucleic acid detection using multiplex amplified probe technique and possibly…	110	$90	$10.2K
87486	The lab analyst performs a test for Chlamydia pneumoniae using amplified nucleic acid probe technique. Chlamydia pneumoniae also known as TWAR, Taiwan Acute Respiratory agent, commonly causes mild…	250	$30	$8.4K

Showing 1–10 of 21

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Wesley Health System LLC	MS	General Acute Care Hospital	$0	$37.9M
Aaa Ambulance Service	MS	Land Ambulance	$5.2M	$20.1M
Wright Lauten	MS	Retina Specialist (Ophthalmology) Physician	$11.8M	$20.3K
Middleton & Belknap Pediatric Dentistry PLLC	MS	Pediatric Dentistry	$0	$11.3M
Hattiesburg Clinic PA	MS	Pediatrics Physician	$0	$10.9M
Metro Medical Supply Company LLC	MS	Durable Medical Equipment & Medical Supplies	$0	$10.2M
Hattiesburg Road Dental, P.C.	MS	General Practice Dentistry	$0	$10.1M
Wesley Physician Services LLC	MS	Family Medicine Physician	$0	$8.2M
Latonya Hailes	MS	Community Health Worker	$0	$8M
Oral & Maxillofacial Surgery Clinic Of South Misssissippi, P.A.	MS	Oral and Maxillofacial Surgery (Dentist)	$0	$7.4M

Proteus Genomics, LLC — Billing Profile & Reimbursement Data

Sign up for Proteus Genomics, LLC — Billing Profile & Reimbursement Data policy alerts

Proteus Genomics, LLC — Billing Profile & Reimbursement Data

Sign up for Proteus Genomics, LLC — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
87798	1	50	1,050	$30	$144.9K
87481	1	40	540	$30	$61.5K
U0003	5	10	270	$70	$51.4K
87631	2	10	60	$140	$22.8K
U0005	6	10	250	$20	$15.9K
87500	1	30	130	$30	$14.5K
87506	2	10	60	$240	$14.1K
87653	1	40	130	$30	$13.6K
87640	1	50	90	$30	$10.4K
87641	1	40	70	$30	$9.5K